Inhibition of the phosphatidylinositol 3′-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes

Metabolism: Clinical and Experimental

Volumn 54, Issue 12, 2005, Pages 1636-1643

  Pereira, Rocio I ^a   Draznin, Boris ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ADENOVIRUS; ADIPOCYTE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; INSULIN; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 28444494407     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.07.002     Document Type: Article

References (57)

1. M. Chandran, S.A. Phillips, T. Ciaraldi, and R.R. Henry Adiponectin: more than just another fat cell hormone? Diabetes Care 26 2003 2442 2450
2. M. Fasshauer, and R. Paschke Regulation of adipocytokines and insulin resistance Diabetologia 46 2003 1594 1603
3. U. Meier, and A.M. Gressner Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin Clin Chem 50 2004 1511 1525
4. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem Biophys Res Commun 221 1996 286 289
5. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
6. E. Hu, P. Liang, and B.M. Spiegelman AdipoQ is a novel adipose-specific gene dysregulated in obesity J Biol Chem 271 1996 10697 10703
7. Y. Nakano, T. Tobe, N.H. Choi-Miura, T. Mazda, and M. Tomita Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma J Biochem (Tokyo) 120 1996 803 812
8. T.P. Combs, U.B. Pajvani, A.H. Berg, Y. Lin, L.A. Jelicks, and M. Laplante A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity Endocrinology 145 2004 367 383
9. U.B. Pajvani, and P.E. Scherer Adiponectin: systemic contributor to insulin sensitivity Curr Diab Rep 3 2003 207 213
10. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, and K. Hara The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
11. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, and Y. Okamoto Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
12. Y. Nakamura, K. Shimada, D. Fukuda, Y. Shimada, S. Ehara, and M. Hirose Implications of plasma concentrations of adiponectin in patients with coronary artery disease Heart 90 2004 528 533
13. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
14. Z. Dzielinska, A. Januszewicz, A. Wiecek, M. Demkow, M. Makowiecka-Ciesla, and A. Prejbisz Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease Thromb Res 110 2003 365 369
15. J. Fernandez-Real, A. Lopez-Bermejo, R. Casamitjana, and W. Ricart Novel interactions of adiponectin with the endocrine system and inflammatory parameters J Clin Endocrinol Metab 88 2003 2714 2718
16. J.V. Silha, M. Krsek, J.V. Skrha, P. Sucharda, B.L. Nyomba, and L.J. Murphy Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance Eur J Endocrinol 149 2003 331 335
17. K. Hotta, T. Funahashi, N.L. Bodkin, H.K. Ortmeyer, Y. Arita, and B.C. Hansen Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Diabetes 50 2001 1126 1133
18. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, and R.E. Pratley Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935
19. P.A. Kern, G.B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression Diabetes 52 2003 1779 1785
20. K. Esposito, A. Pontillo, C. Di Palo, G. Giugliano, M. Masella, and R. Marfella Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial JAMA 289 2003 1799 1804
21. C.L. Addy, A. Gavrila, S. Tsiodras, K. Brodovicz, A.W. Karchmer, and C.S. Mantzoros Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy J Clin Endocrinol Metab 88 2003 627 636
22. N. Ouchi, S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, and Y. Okamoto Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476
23. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes Biochem Biophys Res Commun 290 2002 1084 1089
24. M. Mohlig, U. Wegewitz, M. Osterhoff, F. Isken, M. Ristow, and A.F. Pfeiffer Insulin decreases human adiponectin plasma levels Horm Metab Res 34 2002 655 658
25. J.S. Bogan, and H.F. Lodish Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4 J Cell Biol 146 1999 609 620
26. A.R. Saltiel Diverse signaling pathways in the cellular actions of insulin Am J Physiol 270 1996 E375 E385
27. A. Krook, J.P. Whitehead, S.P. Dobson, M.R. Griffiths, M. Ouwens, and C. Baker Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects J Biol Chem 272 1997 30208 30214
28. B. Cheatham, C.J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C.R. Kahn Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation Mol Cell Biol 14 1994 4902 4911
29. M. Montagnani, I. Golovchenko, I. Kim, G.Y. Koh, M.L. Goalstone, and A.N. Mundhekar Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells J Biol Chem 277 2002 1794 1799
30. C.C. Wang, I. Gurevich, and B. Draznin Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways Diabetes 52 2003 2562 2569
31. C. Sutherland, M. Waltner-Law, L. Gnudi, B.B. Kahn, and D.K. Granner Activation of the ras mitogen-activated protein kinase-ribosomal protein kinase pathway is not required for the repression of phosphoenolpyruvate carboxykinase gene transcription by insulin J Biol Chem 273 1998 3198 3204
32. J. Dorrestijn, D.M. Ouwens, N. Van den Berghe, J.L. Bos, and J.A. Maassen Expression of a dominant-negative Ras mutant does not affect stimulation of glucose uptake and glycogen synthesis by insulin Diabetologia 39 1996 558 563
33. D.F. Lazar, R.J. Wiese, M.J. Brady, C.C. Mastick, S.B. Waters, and K. Yamauchi Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin J Biol Chem 270 1995 20801 20807
34. J.E. Pessin, and A.R. Saltiel Signaling pathways in insulin action: molecular targets of insulin resistance J Clin Invest 106 2000 165 169
35. K. Cusi, K. Maezono, A. Osman, M. Pendergrass, M.E. Patti, and T. Pratipanawatr Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle J Clin Invest 105 2000 311 320
36. Z.Y. Jiang, Y.W. Lin, A. Clemont, E.P. Feener, K.D. Hein, and M. Igarashi Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats J Clin Invest 104 1999 447 457
37. P. Sartipy, and D.J. Loskutoff Monocyte chemoattractant protein 1 in obesity and insulin resistance Proc Natl Acad Sci U S A 100 2003 7265 7270
38. W.A. Hsueh, and R.E. Law Insulin signaling in the arterial wall Am J Cardiol 84 1999 21J 24J
39. M. Nawano, K. Ueta, A. Oku, K. Arakawa, A. Saito, and M. Funaki Hyperglycemia impairs the insulin signaling step between PI 3-kinase and Akt/PKB activations in ZDF rat liver Biochem Biophys Res Commun 266 1999 252 256
40. C.M. Rondinone, L.M. Wang, P. Lonnroth, C. Wesslau, J.H. Pierce, and U. Smith Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus Proc Natl Acad Sci U S A 94 1997 4171 4175
41. U. Smith, M. Axelsen, E. Carvalho, B. Eliasson, P.A. Jansson, and C. Wesslau Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes Ann NY Acad Sci 892 1999 119 126
42. F. Abbasi, J.W. Chu, C. Lamendola, T. McLaughlin, J. Hayden, and G.M. Reaven Discrimination between obesity and insulin resistance in the relationship with adiponectin Diabetes 53 2004 585 590
43. A. Katsuki, Y. Sumida, H. Urakawa, E.C. Gabazza, S. Murashima, and K. Matsumoto Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance Diabetes Care 26 2003 2964 2965
44. Y. Yamamoto, H. Hirose, I. Saito, M. Tomita, M. Taniyama, and K. Matsubara Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population Clin Sci (Lond) 103 2002 137 142
45. H. Murakami, N. Ura, M. Furuhashi, K. Higashiura, T. Miura, and K. Shimamoto Role of adiponectin in insulin-resistant hypertension and atherosclerosis Hypertens Res 26 2003 705 710
46. Y. Okamoto, S. Kihara, N. Ouchi, M. Nishida, Y. Arita, and M. Kumada Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770
47. T. Yamauchi, J. Kamon, H. Waki, Y. Imai, N. Shimozawa, and K. Hioki Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis J Biol Chem 278 2003 2461 2468
48. H. Motoshima, X. Wu, M.K. Sinha, V.E. Hardy, E.L. Rosato, and D.J. Barbot Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone J Clin Endocrinol Metab 87 2002 5662 5667
49. C.R. Kahn, and M.F. White The insulin receptor and the molecular mechanism of insulin action J Clin Invest 82 1988 1151 1156
50. F. Kanai, K. Ito, M. Todaka, H. Hayashi, S. Kamohara, and K. Ishii Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase Biochem Biophys Res Commun 195 1993 762 768
51. A. Krook, R.A. Roth, X.J. Jiang, J.R. Zierath, and H. Wallberg-Henriksson Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects Diabetes 47 1998 1281 1286
52. Y.B. Kim, S.E. Nikoulina, T.P. Ciaraldi, R.R. Henry, and B.B. Kahn Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes J Clin Invest 104 1999 733 741
53. M. Hazel, R.C. Cooksey, D. Jones, G. Parker, J.L. Neidigh, and B. Witherbee Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance Endocrinology 145 2004 2118 2128
54. J.N. Huan, J. Li, Y. Han, K. Chen, N. Wu, and A.Z. Zhao Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance J Biol Chem 278 2003 45638 45650
55. J. Hoffstedt, E. Arvidsson, E. Sjolin, K. Wahlen, and P. Arner Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance J Clin Endocrinol Metab 89 2004 1391 1396
56. N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, and K. Kishida PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 50 2001 2094 2099
57. C.M. Halleux, M. Takahashi, M.L. Delporte, R. Detry, T. Funahashi, and Y. Matsuzawa Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue Biochem Biophys Res Commun 288 2001 1102 1107